[CYCC] YoY Quarter Result on 31-Dec-2010 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
31-Mar-2011
Financial Year
2010
Quarter
31-Dec-2010 [#Q4]
Profit Trend
QoQ- 16.68%
YoY- 26.86%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 299 5 175 138 187 251 12 70.81%
PBT -4,026 -5,067 -3,780 -3,323 -4,489 -8,181 -11,846 -16.44%
Tax -452 -637 -122 -151 -152 -238 -492 -1.40%
NP -3,559 -4,764 -3,658 -3,172 -4,337 -7,943 -11,354 -17.56%
Tax Rate - - - - - - - -
Total Cost 3,858 4,769 3,833 3,310 4,524 8,194 11,366 -16.46%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin -1,190.30 -95,280.00 -2,090.29 -2,298.55 -2,319.25 -3,164.54 -94,616.67 -51.74%
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
EPS -44.87 -149.01 -113.25 -115.84 -229.70 -653.10 -933.56 -39.67%
EPS Diluted -44.87 -149.01 -112.22 -114.43 -229.70 -653.10 -933.56 -39.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.